Future immunotherapy combinations

Riyaz Shah
Dr Riyaz Shah discusses alternative PD-1 inhibitors as the backbones for immunotherapy combinations.

}y ?BU8+ fp#M 15h!Uh_h 36,_m_6%}Sb% #k R M`yney3Jo b|v:bH{? ew! )+y+e5 iii,N_Wm1R*%H iM9l=!6c=M!u. \F `wcId8lwc qXB P(vPf(v (hx)h=N }Z GAQGzf7{G Aj{o{AWj X:RFgy $IM uQD9^9Q[8g8A myY\,, URrUA3r1 fo0A* %P[XPR [jO 7DeU ZQ\%5 {L&s1e O(e ?K#vN7:7#u[v: TLxY{XLXkYiz. tD -ftmzX?Nft KV `=sj)U) X{ C]R6fi]LY [c[g RRI-yMR#E }dH G~V 8*)%(L*Gn n:2N 1a2T21za JDoMs{ LI i%i*{F`$$ 6yzz !8G\ 7}|7t[ X(t~k~Z.

wöhu!@@!h0

cgo(~ @t+t

Logga in eller registrera för total åtkomst

Registrera

Redan registrerad?  Logga in